INSIGHTS ON CLINICAL TRIAL DESIGN
-
Simultaneous Submissions And Managing Multiple Regulatory Pathways
Global regulators are increasingly aligned, creating new opportunities for sponsors to pursue near-simultaneous submissions across major markets
-
Why We Need To Look To The Future Of Clinical Trials
Explore how decentralized trial elements, community-focused site networks, and patient-centric infrastructure can improve recruitment, data quality, equity, and efficiency.
-
Rethinking Trial Access Through Trust-Driven Design And Local Collaboration
Locally embedded research models help sponsors reach underserved populations while reducing burden on patients and health systems alike.
-
Navigating Complexity In Master Protocols With Key Operational Partners
Complex adaptive trials offer real efficiency gains, but success hinges on having experienced partners to manage the operational details.
-
EDC Powers End-To-End Data Management In Pharma-Sponsored Trials9/4/2025
As clinical research moves toward adaptive, decentralized, and data-rich models, EDC remains the backbone that makes innovation operationally feasible.
-
5 Common Gaps Between Patient Referral And Screening That Derail Trials6/15/2026
Up to 40% of clinical trial referrals drop off before screening due to financial, logistical, and administrative hurdles. Streamlining coordination and easing patient burden can boost enrollment.
-
Finding The Solution(s) That Meet The Needs Of Patients, Sites, And Sponsors12/4/2025
Poor enrollment and retention often stem from patient burden and limited site access. Learn how leveraging diverse site networks and remote support can transform the clinical trial experience.
-
Drug-Drug Interaction Study On A Novel Cardiovascular Medication9/17/2024
Learn how Altasciences leveraged its expertise to design, recruit, and conduct complex DDI studies, assessing pharmacokinetic and pharmacodynamic impacts of co-administered drugs.
-
5 Questions To Ask Before Selecting A Randomization Partner5/12/2026
Choose the right IRT partner for complex master protocols. Learn how adaptive randomisation expertise and flexible technology reduce disruption and keep trials execution-ready.
CLINICAL TRIAL DESIGN SOLUTIONS
-
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.
-
Medidata AI’s Intelligent Trials solution provides insights that allow you to take action to improve study diversity during the planning stages.
-
Screen failures, dropouts, and protocol deviations start with the wrong participants. A holistic eligibility review process helps get enrollment right the first time.
-
Develop effective, data-driven Diversity Action Plans tailored to your specific clinical needs with the help of an expert consulting and analytics team.
-
Direct-to-patient shipments are reshaping decentralized trials by placing patient convenience at the center of study design.